Zimmer Biomet’s potential contingent payouts to former Paragon 28 shareholders are dependent on the latter’s 2026 net revenue performance. The full payout of $1.00 per former share will be triggered if the specialized segment’s net revenue reaches or exceeds $361 million in 2026, with a proportional payment for revenues between $346 million and $361 million. The company recently launched the Brachiator™ Mini-Rail fixation system, hoping it will be a catalyst for reaching these financial thresholds.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Zimmer Biomet’s Contingent Payouts Hinge on 2026 Performance Targets
Zimmer Biomet’s potential contingent payouts to former Paragon 28 shareholders are dependent on the latter’s 2026 net revenue performance. The full payout of $1.00 per former share will be triggered if the specialized segment’s net revenue reaches or exceeds $361 million in 2026, with a proportional payment for revenues between $346 million and $361 million. The company recently launched the Brachiator™ Mini-Rail fixation system, hoping it will be a catalyst for reaching these financial thresholds.